Inotek Pharmaceuticals Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

Inotek Pharmaceuticals General Information

Description

Provider of clinical-stage bio-pharmaceutical services intended for providing medicine and mitigating the cellular damage caused by ischemic reperfusion injuries. The company's clinical-stage bio-pharmaceutical services focus on the discovery, development and commercialization of therapies for glaucoma and other eye diseases, thereby enabling scientists and physicians to harness the cytoprotective properties of adenosine.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 131 Hartwell Avenue
  • 1st Floor, Suite 105
  • Lexington, MA 02421
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 131 Hartwell Avenue
  • 1st Floor, Suite 105
  • Lexington, MA 02421
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inotek Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 04-Jan-2018 Completed Profitable
13. Secondary Transaction - Open Market 14-Apr-2017 Completed Clinical Trials - Phase 2
12. PIPE 01-Aug-2016 Completed Profitable
11. Secondary Transaction - Open Market 15-Apr-2016 Completed Clinical Trials - Phase 2
10. 2PO 12-Aug-2015 Completed Clinical Trials - Phase 2
9. IPO 17-Feb-2015 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series AA) 27-Sep-2013 Completed Clinical Trials - General
7. Mezzanine 30-Jun-2013 Completed Clinical Trials - General
6. Later Stage VC (Series AA) 15-Jul-2011 $9.1M $101M Completed Clinical Trials - General
5. Later Stage VC (Series D) 11-Jun-2010 $18M $92.3M Completed Clinical Trials - General
To view Inotek Pharmaceuticals’s complete valuation and funding history, request access »

Inotek Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA
To view Inotek Pharmaceuticals’s complete cap table history, request access »

Inotek Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of clinical-stage bio-pharmaceutical services intended for providing medicine and mitigating the cellular damag
Drug Discovery
Lexington, MA
4 As of 2015

Cambridge, United Kingdom
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inotek Pharmaceuticals Competitors (101)

One of Inotek Pharmaceuticals’s 101 competitors is Foventa Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foventa Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Genentech Formerly VC-backed South San Francisco, CA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
RHEACELL Corporate Backed or Acquired Heidelberg, Germany
Santhera Pharmaceuticals Holding Formerly VC-backed Pratteln, Switzerland
You’re viewing 5 of 101 competitors. Get the full list »

Inotek Pharmaceuticals Patents

Inotek Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2995175-A1 Gate for use in enclosure for passage of piglets, has blocking unit arranged to take up blocked position in which each strip is able to freely move on only one side in balance position and not on another side in balance position Inactive 10-Sep-2012
FR-2991847-B1 Oscillating ventilation trappe around an oscillation axis for a pitch of a farm building Inactive 13-Jun-2012
FR-2991847-A1 Ventilation hatch for pit in livestock building, has flap mounted on frame and movable between open position in which air is allowed to pass through ventilation hatch, and closed position in which air is prevented from crossing hatch Active 13-Jun-2012
FR-2964530-B1 Animal feed dispensing device Inactive 13-Sep-2010
FR-2964530-A1 Dry food e.g. pellet, distributing device for pigs, has stopblock integrated with stopper and extending below stopper till its height such that stopper is accessible by livestock animal, where stopper is supported on base Active 13-Sep-2010 A01K5/0233
To view Inotek Pharmaceuticals’s complete patent history, request access »

Inotek Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inotek Pharmaceuticals Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bio*One Capital Corporate Venture Capital Minority
Care Capital Venture Capital Minority
Devon Park Bioventures Venture Capital Minority
EDBI Venture Capital Minority
Hercules Capital (San Mateo) Lender/Debt Provider Minority
You’re viewing 5 of 12 investors. Get the full list »

Inotek Pharmaceuticals Acquisitions (1)

Inotek Pharmaceuticals’s most recent deal was a Reverse Merger with Rocket Pharmaceuticals. The deal was made on 04-Jan-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rocket Pharmaceuticals 04-Jan-2018 Reverse Merger Biotechnology
To view Inotek Pharmaceuticals’s complete acquisitions history, request access »

Inotek Pharmaceuticals FAQs

  • When was Inotek Pharmaceuticals founded?

    Inotek Pharmaceuticals was founded in 1999.

  • Where is Inotek Pharmaceuticals headquartered?

    Inotek Pharmaceuticals is headquartered in Lexington, MA.

  • What is the size of Inotek Pharmaceuticals?

    Inotek Pharmaceuticals has 4 total employees.

  • What industry is Inotek Pharmaceuticals in?

    Inotek Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Inotek Pharmaceuticals a private or public company?

    Inotek Pharmaceuticals is a Private company.

  • What is Inotek Pharmaceuticals’s current revenue?

    The current revenue for Inotek Pharmaceuticals is .

  • How much funding has Inotek Pharmaceuticals raised over time?

    Inotek Pharmaceuticals has raised $273M.

  • Who are Inotek Pharmaceuticals’s investors?

    Bio*One Capital, Care Capital, Devon Park Bioventures, EDBI, and Hercules Capital (San Mateo) are 5 of 12 investors who have invested in Inotek Pharmaceuticals.

  • Who are Inotek Pharmaceuticals’s competitors?

    Foventa Therapeutics, Genentech, Ability Pharma, RHEACELL, and Santhera Pharmaceuticals Holding are some of the 101 competitors of Inotek Pharmaceuticals.

  • When was Inotek Pharmaceuticals acquired?

    Inotek Pharmaceuticals was acquired on 04-Jan-2018.

  • Who acquired Inotek Pharmaceuticals?

    Inotek Pharmaceuticals was acquired by Rocket Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process